Henry J Tannous

Dr. Henry J Tannous

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
JKJulia E. Katter
Julia E. Katter
JTJohn Paul Tannous
John Paul Tannous
KRKatherine A. Roberts
Katherine A. Roberts
SAShawn M. Ahmad
Shawn M. Ahmad
MYMichael N. Young
Michael N. Young
HTHenry J Tannous
Henry J Tannous
Background: Coronary access following transcatheter aortic valve replacement (TAVR) remains challenging and should be carefully considered when planning re-intervention for patients with structural valve degeneration. Current management options [valve-in-valve (ViV) TAVR or surgical aortic valve replacement and TAVR explant] both carry significant benefits and limitations. Case presentation: A 78-year-old female with a degenerated 23 mm Sapien 3 TAVR presented with severe prosthetic stenosis, moderate paravalvular leak (PVL), and progressive dyspnea. A standard TAVR ViV had a suboptimal risk of not addressing the PVL and worsening prosthesis-patient mismatch, whereas TAVR explantation and SAVR with root enlargement carried an increased surgical risk. Intervention: Open surgical TAVR explantation with direct re-implantation of a 26 mm Sapien Ultra valve, combined with selective metal cells excision facing the left main coronary artery (LMCA) and felt patch repair of the PVL. Outcome: The patient achieved immediate resolution of severe stenosis and elimination of PVL, with sustained clinical improvement at six-month follow-up and a more favorable coronary access. Conclusion: Selective metal cell excision during open TAVR implantation is a technically feasible approach to prophylactically preserve coronary access while maintaining valve integrity and function. This technique may benefit high-risk patients requiring TAVR explants and root enlargement SAVRs.

8 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JKJulia Elaine Katter
Julia Elaine Katter
JRJonathan Martinez Rivera
Jonathan Martinez Rivera
MMMeghan Matlack
Meghan Matlack
DADaniel A. Anderson
Daniel A. Anderson
ELEmily K. Leva
Emily K. Leva
HTHenry J Tannous
Henry J Tannous
Surgical mitral valve repair is the gold standard for severe primary mitral regurgitation (MR), yet when repairs fail, open reintervention carries substantial perioperative risk. Following band annuloplasty, minimally invasive options, such as transcatheter mitral valve replacement (TMVR), remain largely unexplored due to a hypothetical concern around the lack of circumferential radial support. Although transapical transcatheter mitral valve-in-band (ViB) replacement has been reported in a single human case, we report the first controlled large-animal model of ViB. A 68 kg, 20-month-old female Yucatan mini pig underwent placement of a 28 mm mitral annuloplasty band, oversized to create MR, via clamshell sternotomy under cardiopulmonary bypass; a simulated dilated left atrium enabled transcatheter access. A 23 mm Edwards SAPIEN 3 Ultra valve was deployed within the band using the Commander delivery system under fluoroscopic guidance. The valve achieved stable fixation without embolization, paravalvular leak (PVL), or left ventricular outflow tract (LVOT) obstruction with resolution of MR on echocardiography. The stable position was consistent with a contribution from the native anterior leaflet and annulus, although radial forces were not directly measured. The animal tolerated the procedure without complications. This first-in-animal study suggests the acute technical feasibility of TMVR within a mitral annuloplasty band and supports further investigation of percutaneous band modification strategies to optimize ViB outcomes.

12 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
JKJulia Elaine Katter
Julia Elaine Katter
JRJonathan Martinez Rivera
Jonathan Martinez Rivera
MMMeghan Matlack
Meghan Matlack
DADaniel Anderson
Daniel Anderson
ELEmily K. Leva
Emily K. Leva
HTHenry J Tannous
Henry J Tannous
Surgical mitral valve repair is the gold standard for severe primary mitral regurgitation (MR), yet when repairs fail, open reintervention carries substantial perioperative risk. Following band annuloplasty, minimally invasive options, such as transcatheter mitral valve replacement (TMVR), remain largely unexplored due to a hypothetical concern around the lack of circumferential radial support. We report the first transcatheter mitral valve-in-band (ViB) replacement in a large-animal model of failed mitral repair. A 68 kg, 20-month-old female Yucatan mini pig underwent placement of a 28 mm mitral annuloplasty band, oversized to create MR, via clamshell sternotomy under cardiopulmonary bypass; a simulated dilated left atrium enabled transcatheter access. A 23 mm Edwards Sapien Ultra valve was deployed within the band using the Commander delivery system under fluoroscopic guidance. The valve achieved stable fixation without embolization, paravalvular leak (PVL), or left ventricular outflow tract (LVOT) obstruction with resolution of MR on echocardiography. The native anterior leaflet and annulus contributed circumferential radial support, and the animal tolerated the procedure without complications. This first-in-animal study demonstrates the technical feasibility and acute safety of TMVR within a mitral annuloplasty band and supports further investigation of percutaneous band modification strategies to optimize ViB outcomes.

15 October 2025 in American Heart Journal Plus: Cardiology Research and Practice
Verified
Journal Article
Open access
JMJasper Murphy
Jasper Murphy
NKNatalie K. Kolba
Natalie K. Kolba
IWIan T. Winkeler
Ian T. Winkeler
LHLichun He
Lichun He
DLDeborah Li
Deborah Li
ASA. Laurie Shroyer
A. Laurie Shroyer